Tendinopathy
Conditions
Keywords
Greater Trochanter Pain Syndrome, Lateral hip pain
Brief summary
This pragmatic clinical trial is considering the variable response to treatment outcome of individuals with Greater Trochanteric Pain Syndrome (GTPS). The aim of this study is to identify predictors of focused extracorporeal shockwave therapy (fESWT) efficacy in individuals with GTPS. Specifically, the ability of clinically applicable measurements including: Patient demographics, co-morbidity, oestrogen levels, pain characteristics, hip abductor strength, time to pain during single-leg stance test, low back pain, and immediate pain reduction to local anaesthetic injection at the trochanter major insertion of Gluteus medius (GMed) during walking.
Interventions
COMBINATION_PRODUCTFocused shockwave therapy
3 session of shockwave therapy. The wave is focused through a standoff and transmitted into the tissue. Enhanced Energy: 0.01 - 0.55mJ/mm2. Broad Frequency Range: 1 - 8Hz. 12.5 cm penetration with pinpoint focus. The patient will be treated in the lateral decubitus position. The shock wave will focus on the area of maximal tenderness, which will be treated in a circumferential pattern.
Sponsors
University of Canberra
Aalborg University Hospital
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
35 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
* Lateral hip pain, worst over the greater trochanter, present for a minimum of 3 months * Age 35-70 years * Female * Pain at an average intensity of ≥3 out of 10 on most days of the last week. * Tenderness on palpation of the greater trochanter * Pain on one of the following: Reproduction of pain on 30 sec single leg stand OR Positive Faber test
Exclusion criteria
* Any known advanced hip joint pathology where groin pain is the primary complaint and/or reproduction of groin pain with Faber or FADDIR. * Where range of pure hip joint flexion is \<90° * Radiating pain distal to the Gluteus Max + positive Straight Leg Raise (SLR-test \< 30°) * Known advanced knee pathology or restricted range of knee motion (must have minimum 90° flexion and full extension) * Any systemic diseases affecting the muscular or nervous system, and uncontrolled diabetes * Malignant tumour OR Systemic inflammatory disease * Any factors that would preclude the participant from having an MRI (e.g. pacemaker, metal implants, pregnancy, claustrophobia) * If the participant is involved in a legal/workcover or other injury claim * Fear of needles (trypanophobia) * If the participant is unable to write, read or comprehend Danish
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Global Rating of Change Scale | 3 months follow-up |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Muscle strength Static | 0, 12 and 26 weeks follow-up | Hip abduction strength |
| Pain Pressure Threshold | 0, 12 and 26 weeks follow-up | Lateral hip region |
| EuroQoL | 0, 12 and 26 weeks follow-up | EQ-5D™ |
| PHQ9 | 0, 12 and 26 weeks follow-up | Severity of depression |
| VISA-G | 0, 12 and 26 weeks follow-up | disability score for gluteal tendinopathy |
| Patient-Specific Functional Scale). | 0, 6, 12 and 26 weeks follow-up | difficulties with 1-5 functional tasks |
Countries
Denmark
Contacts
Primary ContactCarsten M Molgaard, PhD
Backup ContactJens Kristinsson, MD
Outcome results
None listed